GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Awakn Life Sciences Corp (FRA:954) » Definitions » Valuation Rank

Awakn Life Sciences (FRA:954) Valuation Rank


View and export this data going back to 2021. Start your Free Trial

What is Awakn Life Sciences Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Awakn Life Sciences Valuation Rank Related Terms

Thank you for viewing the detailed overview of Awakn Life Sciences's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Awakn Life Sciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Awakn Life Sciences Corp (FRA:954) » Definitions » Valuation Rank
Comparable Companies
TSXV:XRTX TSX:APLI XCNQ:LOBE XCNQ:MBIO XCNQ:ENBI XCNQ:ASEP XCNQ:RIZE XCNQ:MYND TSXV:QPT XCNQ:NIRV VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY BNTX XKRX:068270 ONC
Traded in Other Exchanges
N/A
Address
301?217 Queen Street West, Toronto, ON, CAN, M5V 0R2
Website
https://www.awaknlifesciences.com
Awakn Life Sciences Corp is a clinical-stage biotechnology company intended to develop therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder. The Company focuses on Alcohol Use Disorder (AUD), a condition affecting people in the US and key international markets and many people globally for which the current standard of care is inadequate, enabling it to provide breakthrough therapeutics to addiction sufferers in desperate need.